• Search
    Generic filters
Transforming cancer care at all stages of the disease
AJ Patel
7-year stage IV lung cancer survivor

Transforming cancer care at all stages of the disease

We are dedicated to helping patients at all stages of cancer live longer and healthier, through the power of blood tests and the data they unlock. Today our FDA-approved test helps inform treatment decisions for patients with advanced cancer. Our tests also detect residual and recurrent disease for patients with early-stage cancer, and will soon screen to find cancer at its earliest and most treatable.

Learn more
June 13, 2022

Guardant Health Completes Purchase of Guardant Health AMEA Joi...

Guardant Health today announced it has purchased the remaining shares of Guardant Health AMEA, Inc., h...
READ MORE
May 25, 2022

First Guardant Health Liquid Biopsy Testing Service in Europe ...

The first blood-based cancer testing services in Europe based on Guardant Health’s industry-leading di...
READ MORE
May 23, 2022

Guardant Health to Present New Data from its Broad Portfolio o...

Guardant Health, Inc. announced today it will present new data at the 2022 American Society of Clinica...
READ MORE
May 21, 2022

Guardant Health Presents New Data Showing Blood Test Accuracy ...

Guardant Health, Inc. today announced data showing its blood-based multimodal test achieved clinically...
READ MORE
May 2, 2022

Guardant Health Announces Shield™ Blood Test Available in US t...

Highly sensitive Shield test offers convenient screening method that can be completed with simple bloo...
READ MORE
April 11, 2022

Guardant Health Presents New Data Showing Blood Test Highly Ac...

New data demonstrating the ability of the company’s investigational next-generation Guardant SHIELD™ m...
READ MORE
See all press releases
Precision oncology

Delivering on the promise for patients

Precision oncology is redefining cancer care by driving a more personalized and data-driven approach that improves on traditional standards of care. From using biomarkers to inform treatment in advanced cancer, to using circulating tumor DNA to not only assess response to treatment, but detect signs of remaining cancer and even identify the earliest signs of cancer, precision oncology is helping patients across all stages of the disease.

Learn more
Products

Blood tests are at the core of our mission

Blood is at the center of transforming cancer care by holding insights that can improve clinical outcomes. Over 200,000 of our blood tests have been performed by 9,000 doctors to date. Our commercially available tests help inform treatment decisions for patients with advanced cancer, monitor treatment response, detect residual and recurrent disease in patients with early-stage cancer, and soon may help screen for cancer before symptoms appear. Our products also help pharmaceutical companies develop the next generation of cancer therapies.

    • “Our focus is always on what will have the greatest impact on patients.”
    Helmy Eltoukhy, co-CEO
    Careers

    Together we can help conquer cancer

    When you join our team, you become part of a mission that impacts so many personally: conquering cancer with data. We are passionate about serving patients and their families through the power of blood and the life-changing information it holds. Guardant Health is hiring bright minds in diverse fields to solve some of the most profound challenges in human health today.

    Learn more